Vaxxa AB (FRA:7WA0) ROCE %: -47.88% (As of Mar. 2026)


FRA:7WA0 Vaxxa AB FRA:7WA0
22 GF Score
Price €0.03
GF Value €0.05
! 2 Warning Signs
View Full Analysis

What is Vaxxa AB ROCE %?

Vaxxa AB FRA:7WA0 +0.65% 22 ROCE % is -47.88% as of Mar. 2026. GuruFocus rates FRA:7WA0 with a GF Score™ of 22/100 and a GF Value™ of €0.05. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vaxxa AB's annualized ROCE % for the quarter that ended in Mar. 2026 was -47.88%.

Vaxxa AB  (FRA:7WA0) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vaxxa AB ROCE % Related Terms

Vaxxa AB ROCE % Historical Data

* Premium members only.

The historical data trend for Vaxxa AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxxa AB ROCE % Chart

Vaxxa AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -75.79 -339.27 -34.39 3.31 -54.27

Vaxxa AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.14 -28.57 -11.56 -25.38 -47.88
FRA:7WA0
22GF Score
Vaxxa AB FRA:7WA0
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxxa AB ROCE % Calculation

Vaxxa AB's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-0.855/( ( (2.419 - 0.659) + (2.034 - 0.643) )/ 2 )
=-0.855/( (1.76+1.391)/ 2 )
=-0.855/1.5755
=-54.27 %

Vaxxa AB's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-0.632/( ( (2.034 - 0.643) + (2.416 - 1.167) )/ 2 )
=-0.632/( ( 1.391 + 1.249 )/ 2 )
=-0.632/1.32
=-47.88 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -47.88% mean?
Vaxxa AB (FRA:7WA0) has a ROCE % of -47.88% as of Mar. 2026.
Is Vaxxa AB's ROCE % too high?
Vaxxa AB's current ROCE % is -47.88%. Overall, Vaxxa AB has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Vaxxa AB's ROCE % compare to CRM and SHOP?
Vaxxa AB's ROCE % of -47.88% can be compared against companies in the Software industry. The industry median ROCE % is 5.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Software company?
The median ROCE % among Software companies is 5.27, based on 2,713 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Software industry, the median ROCE % is 5.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vaxxa AB's current ROCE % is -47.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxxa AB stock overvalued right now?
Vaxxa AB (FRA:7WA0) has a current ROCE % of -47.88%. The stock's GF Value™ is €0.05, compared to a current price of €0.03 — trading 37.6% below its estimated fair value. The current ROCE % is -47.88%. Vaxxa AB's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Vaxxa AB (FRA:7WA0), the current ROCE % is -47.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vaxxa AB (FRA:7WA0) Overvalued in 2026?

Based on GuruFocus' analysis, Vaxxa AB stock appears to be undervalued. The current stock price of €0.03 is trading 37.6% below its estimated GF Value™ of €0.05.

Key valuation signals for FRA:7WA0:

  • ROCE %: -47.88%
  • GF Value™: €0.05 vs. price of €0.03 (37.6% below fair value)
  • GF Score™: 22/100 with 2 warning signs

No single metric tells the full story. See the FRA:7WA0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vaxxa AB Business Description

Other Exchanges VAXXA:Sweden
Address Maskinvagen 27, Norrbotten, Lulea, SWE, 972 54
Vaxxa AB is the auction site for those who want to buy and sell objects in vehicles, machinery, construction and industry. The company want to make it more accessible for both private individuals and companies to sell their objects with the motivation to pave the way for a more circular market. Vaxxa is Sweden's only auction platform where exactly the combination of auction broker and self-service is offered.
22GF Score

Get the complete analysis for FRA:7WA0

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price
€0.05
GF Value